Degrome Therapeutics, Inc.

Biotechnology company · Indianapolis, Indiana, United States

Degrome Therapeutics, Inc. is a biotechnology company headquartered in Indianapolis, Indiana, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $499,883 in total, most recently in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Degrome Therapeutics at a glance

Typebiotechnology company

HeadquartersIndianapolis, Indiana, United States

Employees (self-reported, 2024)2

What does Degrome Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $499,883 in total (2024). NIH funding came from the National Institute on Aging.

Frequently asked questions about Degrome Therapeutics

Where is Degrome Therapeutics headquartered?

Degrome Therapeutics, Inc. is headquartered in Indianapolis, Indiana, United States.

What does Degrome Therapeutics do?

Degrome Therapeutics, Inc. is a biotechnology company.

Similar companies

Scioto Biosciences, Inc.Indianapolis, Indiana, United States
PharmacoPhotonics, Inc.Indianapolis, Indiana, United States
Kovina Therapeutics Inc.Indianapolis, Indiana, United States
Adipo Therapeutics, LLCIndianapolis, Indiana, United States
Grannus Therapeutics, Inc.Indianapolis, Indiana, United States
NERx Biosciences, Inc.Indianapolis, Indiana, United States
PinkDx, Inc.Indianapolis, Indiana, United States
Animated Dynamics, Inc.Indianapolis, Indiana, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences